Advertisement
CEO and President J. Tobin Geatz said: "We are excited to have theseaccomplished industry professionals on board to strengthen our leadershipteam. Having previously helped other innovative companies accelerate theirrevenues and growth paths, these executives, without doubt, are equipped andready to guide Inclinix during this time of tremendous growth."
Advertisement
About Inclinix
Founded in 1999, Inclinix, Inc., is the industry's Enrollment CRO.Inclinix's IQM(TM) Intelligent Enrollment process uses technology to amplifytraditional services and is proven to accelerate trials for pharmaceutical,biotechnology and medical-device organizations. In addition to its clinicalresearch-related offerings, Inclinix provides strategic medical marketingcommunications and adherence services to the healthcare industry. For moreinformation on Inclinix, visit www.inclinix.com-- Steven M. Agnoff, has joined the company in the position of Vice President of Marketing and Product Management. In this role, Mr. Agnoff provides strategic direction to the corporate marketing and product marketing functions of the company and oversees product management efforts. Prior to joining Inclinix, Mr. Agnoff held executive leadership and business development roles with organizations including PDI, Inc., PharmaKon, Fenner PLC, Efson, Inc. and Interroll Corporation. -- Daniel D. Marks, has joined the company as Vice President of Corporate Development. In this role, Mr. Marks is responsible for the evaluation and execution of Inclinix's strategic investments, joint ventures and acquisitions. Before joining Inclinix, he held executive management roles within the technology and medical services sectors. -- Jeffrey L. Bagshaw, has been named Senior Vice President of Sales. In this role, Mr. Bagshaw is responsible for leading sales operations of Inclinix. Prior to this role, he served as vice president of medical marketing and communications at Inclinix. Prior to joining Inclinix, Mr. Bagshaw held sales and marketing leadership roles at organizations including Hoffman La Roche, Bristol Myers Squibb and Exact Sciences. Newly-reporting to Mr. Bagshaw is: -- Susan A. Jalbert, who has joined the company as Director of North American Sales. In this role, Ms. Jalbert has responsibility for managing strategic client relationship development and tactical sales efforts with Inclinix's expanded sales team. Prior to joining Inclinix, Ms. Jalbert held sales and business development leadership positions at Medidata Solutions, Relsys International, Inc., Domain Pharma Corporation, Neuromedical Systems, Inc. and the Corning Nichols Institute. Now reporting to Ms. Jalbert are: - Ashley Amstutz, sales executive; - Jeffrey Cazeault, sales executive; - Svetlana Gorodetsky, sales executive; - Matt Granger, sales executive; - Askold Kozbur, sales executive; - Tom McCollum, senior sales executive; - Stephen Scaldaferri, sales executive; and - Christine Ward, sales executive.
SOURCE Inclinix, Inc.
